Polymorphisms of TERT and CLPTM1L and the Risk of Hepatocellular Carcinoma in Chinese Males

Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer—A case–control study in a Chinese population

(2013) Ajay A. Myneni et al.   LUNG CANCER

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

(2012) Qiujin Shen et al.   LANCET ONCOLOGY

Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus

(2012) Michael A. James et al.   PLoS One

CLPTM1L Is Overexpressed in Lung Cancer and Associated with Apoptosis

(2012) Zhenhua Ni et al.   PLoS One

Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population

(2011) Yingjie Zhao et al.   INTERNATIONAL JOURNAL OF CANCER

Telomere Biology and Telomere Diseases: Implications for Practice and Research

(2011) N. S. Young   Hematology-American Society of Hematology Education Program

Telomeres in cancer and ageing

(2010) L. E. Donate et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Polymorphisms in Telomere Maintenance Genes and Risk of Lung Cancer

(2009) J. E. Choi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Telomeres and telomerase in cancer

(2009) S. E. Artandi et al.   CARCINOGENESIS

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types

(2009) Thorunn Rafnar et al.   NATURE GENETICS

Common 5p15.33 and 6p21.33 variants influence lung cancer risk

(2008) Yufei Wang et al.   NATURE GENETICS